## Diagnosis: Rh Incompatibility (Hemolytic Disease of the Newborn) ### Clinical Presentation The constellation of findings strongly suggests Rh incompatibility: - **Rh-negative mother** (key risk factor) - **Jaundice at 48 hours** (early onset, typical of Rh disease) - **Positive Coombs test** (confirms antibody-mediated hemolysis) - **Spherocytes on smear** (RBC destruction pattern) - **Anemia (Hb 10.2 g/dL)** with elevated reticulocyte count (8%) - **Unconjugated hyperbilirubinemia** (18 mg/dL is significant at 48 hours) - **Prematurity (36 weeks)** (increases risk of bilirubin encephalopathy) ### Pathophysiology **Key Point:** Rh incompatibility occurs when maternal anti-D IgG antibodies (from prior sensitization or fetomaternal hemorrhage during delivery) cross the placenta and bind to D antigen on fetal RBCs, causing hemolysis and anemia. **High-Yield:** Although the mother was "not previously sensitized," sensitization can occur during pregnancy (especially with fetal distress and emergency cesarean, which increase fetomaternal hemorrhage risk) or even during delivery itself. The presence of a positive Coombs test in the baby confirms active hemolysis. ### Why This Is Rh Disease, Not ABO Incompatibility | Feature | This Case | ABO Incompatibility | Rh Incompatibility | | --- | --- | --- | --- | | **Maternal blood group** | Rh-negative | O-positive | Rh-negative | | **Severity of anemia** | Hb 10.2 (moderate) | Mild anemia | Moderate-to-severe | | **Spherocytes on smear** | Yes (prominent) | Rare/absent | Yes (characteristic) | | **Jaundice timing** | 48 hours (early) | Day 1–3 (variable) | Day 2–7 (often severe) | | **Reticulocyte response** | 8% (brisk) | Mild elevation | Brisk (>8%) | | **First pregnancy** | Can be affected if sensitized | Often mild | Usually spares first | **Clinical Pearl:** The presence of **spherocytes** on peripheral smear is a key differentiator. Spherocytes result from repeated passage of RBCs through the spleen as antibodies attack the cell surface, removing membrane fragments. This is characteristic of Rh disease but not typical of ABO incompatibility (where RBCs retain normal morphology). ### Mechanism of Rh Sensitization in This Case 1. **Emergency cesarean for fetal distress** → increased fetomaternal hemorrhage 2. **Rh-negative mother exposed to fetal Rh-positive blood** → maternal immune system primed 3. **Maternal IgG anti-D antibodies form** (can occur during pregnancy or immediately postpartum) 4. **IgG crosses placenta** → binds D antigen on fetal RBCs 5. **Hemolysis, anemia, jaundice, and bilirubin encephalopathy risk** → clinical disease ### Management Algorithm ```mermaid flowchart TD A[Rh-negative mother + Positive Coombs in baby]:::outcome --> B[Check bilirubin level vs phototherapy threshold]:::action B --> C{Bilirubin above threshold for age?}:::decision C -->|Yes| D[Phototherapy + prepare for exchange transfusion]:::action C -->|No| E[Phototherapy + monitor q4-6h]:::action D --> F{Bilirubin response adequate?}:::decision F -->|Yes| G[Continue phototherapy]:::action F -->|No| H[Exchange transfusion with Rh-negative blood]:::urgent E --> I{Bilirubin rising or Hb dropping?}:::decision I -->|Yes| J[Consider top-up transfusion]:::action I -->|No| K[Discharge with follow-up]:::action ``` **Mnemonic:** **RhD** = **Rh**-negative mother + **D**isease in baby ### Prevention in Future Pregnancies **Key Point:** The mother should receive **anti-D immunoglobulin (RhIG)** immediately postpartum (or even antenatally if sensitization is suspected) to prevent alloimmunization and protect future pregnancies. - **Dose:** 500 IU/kg fetal RBCs (or 100 IU per mL of fetal RBCs) - **Timing:** Within 72 hours of delivery (ideally within 48 hours) - **Efficacy:** Prevents sensitization in ~95% of cases if given promptly [cite:Nelson Textbook of Pediatrics 21e Ch 102; Harrison 21e Ch 142] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.